Voluntary family planning is a vital component of global health. Access to contraceptives results in fewer mothers dying during pregnancy and childbirth, fewer unintended pregnancies, fewer abortions, and fewer infant deaths. But more than 220 million women in developing countries lack access to safe and effective contraceptives. One of the barriers is a lack of appropriate, affordable products that meet their needs.
We invested in Levoplant, a three-year contraceptive implant that is highly effective, easy to use, safe, and inexpensive. It is made up of silicone rods that are inserted under the skin; the rods contain levonorgestrel, a synthetic version of the natural hormone progesterone.
Manufactured by Shanghai Dahua Pharmaceutical Co., the product has received WHO prequalification.